LakeShore Biopharma Co Total Liabilities

As of the most recent data (March 2025), YS shows a total liabilities of $870M. That compares with $930M in the prior-year period — down 6.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, YS's total liabilities is now $870M (was $930M) — a 6.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether LakeShore Biopharma Co is outperforming or lagging.

Tracking YS's total liabilities over time shows whether LakeShore Biopharma Co is scaling, shrinking, or reshaping that part of the business. The current reading is $870M That compares with $930M in the prior-year period — down 6.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has LakeShore Biopharma Co's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $870M) with ownership activity and broader fundamentals.